Call E4C Biology and screening

A call for collaboration for access to screening facilities for rationally selected compounds against SARS-CoV-2 Background as be opened.

Exscalate4CoV (acronym E4C) is an EU-funded project that was selected after the emergency Call of expression of interest that the European Commission (DG RTD) issued on 31 January.

The project will receive a 3 million EUR of EU funding in the next 18 months. Organisations are invited  to submit proposals for screening of their compounds for efficacy profiling on the E4C Biology platforms

Full criteria and conditions are defined in the “Drug-Box” submission portal on the E4C website

More information available here